Clinical Trials Browser

OTHER × beta-Glucans × Dermatologic × Clear all

NCT04513028 2025-10-30

Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma

Phase NA Recruiting

Melanoma